BMC Medical Genetics (Mar 2010)

Genetic modifiers of Hb E/β<sup>0 </sup>thalassemia identified by a two-stage genome-wide association study

  • Winichagoon Pranee,
  • Makarasara Wattanan,
  • Angkachatchai Vach,
  • Whitacre Johanna,
  • Ma Qianli,
  • Abel Kenneth,
  • Sripichai Orapan,
  • Sherva Richard,
  • Svasti Saovaros,
  • Fucharoen Suthat,
  • Braun Andreas,
  • Farrer Lindsay A

DOI
https://doi.org/10.1186/1471-2350-11-51
Journal volume & issue
Vol. 11, no. 1
p. 51

Abstract

Read online

Abstract Background Patients with Hb E/β0 thalassemia display remarkable variability in disease severity. To identify genetic modifiers influencing disease severity, we conducted a two-stage genome scan in groups of 207 mild and 305 severe unrelated patients from Thailand with Hb E/β0 thalassemia and normal α-globin genes. Methods First, we estimated and compared the allele frequencies of approximately 110,000 gene-based single nucleotide polymorphisms (SNPs) in pooled DNAs from different severity groups. The 756 SNPs that showed reproducible allelic differences at P Results After adjustment for age, gender and geographic region, logistic regression models showed 50 SNPs significantly associated with disease severity (P P = 2.6 × 10-13). Seven SNPs in two distinct LD blocks within a region centromeric to the β-globin gene cluster that contains many olfactory receptor genes were also associated with disease severity; rs3886223 had the strongest association (OR = 3.03, P = 3.7 × 10-11). Several previously unreported SNPs were also significantly associated with disease severity. Conclusions These results suggest that there may be an additional regulatory region centromeric to the β-globin gene cluster that affects disease severity by modulating fetal hemoglobin expression.